Real-time enrollment status for this depressive disorder, major clinical trial
Current Status
Recruiting
Checked: October 1, 2026 at 10:00 PM UTC
| NCT Number | NCT07775300 |
| Recruiting Status | Recruiting |
| Condition | Depressive Disorder, Major |
| Phase | PHASE3 |
| Target Enrollment | 1,000 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | October 1, 2026 (22 hours ago) |
As of October 1, 2026: Clinical trial NCT07775300 is currently recruiting participants. This phase3 study for depressive disorder, major is actively seeking new participants at 33 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07775300 is actively recruiting participants as of October 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07775300 was last updated 22 hours ago (October 1, 2026). HelloStudys verifies this status automatically.